{"id":152191,"date":"2020-11-19T05:11:28","date_gmt":"2020-11-19T10:11:28","guid":{"rendered":"https:\/\/www.immortalitymedicine.tv\/prevail-therapeutics-granted-composition-of-matter-patent-for-experimental-gene-therapy-program-pr001\/"},"modified":"2024-08-18T11:40:28","modified_gmt":"2024-08-18T15:40:28","slug":"prevail-therapeutics-granted-composition-of-matter-patent-for-experimental-gene-therapy-program-pr001","status":"publish","type":"post","link":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/global-news-feed\/prevail-therapeutics-granted-composition-of-matter-patent-for-experimental-gene-therapy-program-pr001.php","title":{"rendered":"Prevail Therapeutics Granted Composition of Matter Patent for Experimental Gene Therapy Program PR001"},"content":{"rendered":"<p><![CDATA[NEW YORK, Nov.  18, 2020  (GLOBE NEWSWIRE) -- Prevail Therapeutics Inc. (Nasdaq: PRVL), a biotechnology company developing potentially disease-modifying AAV-based gene therapies for patients with neurodegenerative diseases, today announced that the United States Patent and Trademark Office (USPTO) on\u00a0November 17, 2020\u00a0issued a composition of matter patent, U.S. Patent No. 10,837,028,\u00a0with claims directed to the AAV vector used in PR001, Prevail\u2019s experimental gene therapy program for the treatment of Parkinson\u2019s disease with GBA1 mutations (PD-GBA) and neuronopathic Gaucher disease (nGD). The base patent term extends until October 3, 2038, excluding patent term extensions or coverage in additional related patent filings.]]><\/p>\n<p>Original post:<br \/>\n<a target=\"_blank\" rel=\"nofollow noopener noreferrer\" href=\"http:\/\/www.globenewswire.com\/news-release\/2020\/11\/19\/2129714\/0\/en\/Prevail-Therapeutics-Granted-Composition-of-Matter-Patent-for-Experimental-Gene-Therapy-Program-PR001.html?f=22&amp;fvtc=5&amp;fvtv=46634288\" title=\"Prevail Therapeutics Granted Composition of Matter Patent for Experimental Gene Therapy Program PR001\">Prevail Therapeutics Granted Composition of Matter Patent for Experimental Gene Therapy Program PR001<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Original post: Prevail Therapeutics Granted Composition of Matter Patent for Experimental Gene Therapy Program PR001 <a href=\"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/global-news-feed\/prevail-therapeutics-granted-composition-of-matter-patent-for-experimental-gene-therapy-program-pr001.php\">Continue reading <span class=\"meta-nav\">&rarr;<\/span><\/a><\/p>\n","protected":false},"author":64,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"limit_modified_date":"","last_modified_date":"","_lmt_disableupdate":"","_lmt_disable":"","footnotes":""},"categories":[1246886],"tags":[],"class_list":["post-152191","post","type-post","status-publish","format-standard","hentry","category-global-news-feed"],"modified_by":null,"_links":{"self":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/152191"}],"collection":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/users\/64"}],"replies":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/comments?post=152191"}],"version-history":[{"count":0,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/152191\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/media?parent=152191"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/categories?post=152191"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/tags?post=152191"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}